Table 3.
Comparison of ANA and antibody levels between the IVIg group and the non-IVIg group.
| ANA/ANA-specific antibodies | IVIg group n (%) |
non-IVIg group n (%) |
Fisher’s | P value |
|---|---|---|---|---|
| ANA | 55(50.93%) | 120(9.99%) | – | <0.0001 |
| speckled pattern | 50(46.3%) | 78(6.49%) | – | <0.0001 |
| cytoplasm particle pattern | 33(30.56%) | 29(2.41%) | – | <0.0001 |
| nucleolar pattern | 2(1.85%) | 15(1.24%) | – | 0.6449 |
| the other patterns | 2(1.85%) | 14(1.17%) | – | 0.3856 |
| anti-nRNP/SM | 3(2.78%) | 11(0.92%) | – | 0.1019 |
| anti-SSA | 42(38.89%) | 3(0.25%) | – | <0.0001 |
| anti-Ro52 | 95(87.96%) | 6(0.50%) | – | <0.0001 |
| anti-SSB | 1(0.93%) | 1(0.08%) | – | 0.1583 |
| anti-Scl70 | 1(0.93%) | 6(0.50%) | – | 0.4535 |
| anti-PM-SCL | 2(1.85%) | 17(1.42%) | – | 0.6662 |
| anti-Jo1 | 0(0%) | 7(0.58%) | – | – |
| anti-PCNA | 1(0.93%) | 9(0.75%) | – | 0.5786 |
| anti-histone | 2(1.85%) | 12(1.00%) | – | 0.3235 |
| anti AMA-Mi2 | 57(52.78%) | 4(0.33%) | – | <0.0001 |
Bold statistical significance.